Metropolis Healthcare launches blood-based test for early Alzheimer’s detection
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Aims to become India’s leading cancer testing company
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated